INTERNATIONAL PATENT: 4M THERAPEUTICS INC. FILES APPLICATION FOR "N-DESMETHYL RUBOXISTAURIN AS A CDK4/6 INHIBITOR FOR THERAPEUTIC USE IN CANCER"

GENEVA, Jan. 27 -- 4M THERAPEUTICS INC. (5 Seminole RoadSkillman, New Jersey 08558) filed a patent application (PCT/US2025/038123) for "N-DESMETHYL RUBOXISTAURIN AS A CDK4/6 INHIBITOR FOR THERAPEUTIC USE IN CANCER" on Jul 17, 2025. With publication no. WO/2026/020038, the details related to the patent application was published on Jan 22, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LAPUERTA, Pablo (c/o 4M Therapeutics Inc.5 Seminole RoadSkillman, New Jersey 08558), LEVY, Daniel E. (c/o 4M Therapeutics Inc.5 Seminole RoadSkillman, New Jersey 08558), MOHANTY, Sarina (c/o 4M Therapeutics Inc...